Microglia in Health and Disease

Overview

Journal Cold Spring Harb Perspect Biol

Specialties Biology
Molecular Biology

Date 2015 Sep 11

PMID 26354893

Citations 148

Authors

Richard M Ransohoff

Joseph El Khoury

Affiliations

Soon will be listed here.

Abstract

Microglia, the major myeloid cells of the central nervous system (CNS) are implicated in physiologic processes and in the pathogenesis of several CNS disorders. Since their initial description early in the 20th century, our ability to identify and isolate microglia has significantly improved and new research is providing insight into the functions of these cells in sickness and in health. Here, we review recent advances in our understanding of the role of microglia in physiological and pathological processes of the CNS with a focus on multiple sclerosis and Alzheimer's disease. Because of the prominent roles CX3CR1 and its ligand fractalkine played in bringing about these advances, we discuss the physiological and pathological roles of microglia as viewed from the CX3CR1-fractalkine perspective, providing a unique viewpoint. Based on the most recent studies of molecular profiling of microglia, we also propose a molecular and functional definition of microglia that incorporates the properties attributed to these cells in recent years.

Citing Articles

Endothelial TDP-43 depletion disrupts core blood-brain barrier pathways in neurodegeneration.

Omar O, Kimble A, Cheemala A, Tyburski J, Pandey S, Wu Q Nat Neurosci. 2025; .

PMID: 40087396 DOI: 10.1038/s41593-025-01914-5.

Divergent Crosstalk Between Microglia and T Cells in Brain Cancers: Implications for Novel Therapeutic Strategies.

Yi M, Lee J, Moon S, So E, Bang G, Moon K Biomedicines. 2025; 13(1).

PMID: 39857798 PMC: 11763300. DOI: 10.3390/biomedicines13010216.

Inflammation and DNA methylation in Alzheimer's disease: mechanisms of epigenetic remodelling by immune cell oxidants in the ageing brain.

Seddon A, MacArthur C, Hampton M, Stevens A Redox Rep. 2024; 29(1):2428152.

PMID: 39579010 PMC: 11587723. DOI: 10.1080/13510002.2024.2428152.

Systematic evaluation of multifactorial causal associations for Alzheimer's disease and an interactive platform MRAD developed based on Mendelian randomization analysis.

Zhao T, Li H, Zhang M, Xu Y, Zhang M, Chen L Elife. 2024; 13.

PMID: 39392298 PMC: 11469671. DOI: 10.7554/eLife.96224.

Protein kinase R induced by type I interferons is a main regulator of reactive microglia in Zika virus infection.

Bortolin V, Mansuroglu Z, Conquet L, Calcagno G, Lambert F, Marin-Obando J Glia. 2024; 73(1):80-104.

PMID: 39359232 PMC: 11660536. DOI: 10.1002/glia.24619.

References

Catalano M, Lauro C, Cipriani R, Chece G, Ponzetta A, Di Angelantonio S . CX3CL1 protects neurons against excitotoxicity enhancing GLT-1 activity on astrocytes. J Neuroimmunol. 2013; 263(1-2):75-82. DOI: 10.1016/j.jneuroim.2013.07.020. View

Clark A, Yip P, Malcangio M . The liberation of fractalkine in the dorsal horn requires microglial cathepsin S. J Neurosci. 2009; 29(21):6945-54. PMC: 2698289. DOI: 10.1523/JNEUROSCI.0828-09.2009. View

Mizoue L, Bazan J, Johnson E, Handel T . Solution structure and dynamics of the CX3C chemokine domain of fractalkine and its interaction with an N-terminal fragment of CX3CR1. Biochemistry. 1999; 38(5):1402-14. DOI: 10.1021/bi9820614. View

Perry V, Hume D, Gordon S . Immunohistochemical localization of macrophages and microglia in the adult and developing mouse brain. Neuroscience. 1985; 15(2):313-26. DOI: 10.1016/0306-4522(85)90215-5. View

Lauro C, Cipriani R, Catalano M, Trettel F, Chece G, Brusadin V . Adenosine A1 receptors and microglial cells mediate CX3CL1-induced protection of hippocampal neurons against Glu-induced death. Neuropsychopharmacology. 2010; 35(7):1550-9. PMC: 3055460. DOI: 10.1038/npp.2010.26. View

Cook D, Chen S, Sullivan L, Manfra D, Wiekowski M, Prosser D . Generation and analysis of mice lacking the chemokine fractalkine. Mol Cell Biol. 2001; 21(9):3159-65. PMC: 86945. DOI: 10.1128/MCB.21.9.3159-3165.2001. View

Garcia J, Pino P, Mizutani M, Cardona S, Charo I, Ransohoff R . Regulation of adaptive immunity by the fractalkine receptor during autoimmune inflammation. J Immunol. 2013; 191(3):1063-72. PMC: 3720756. DOI: 10.4049/jimmunol.1300040. View

Hundhausen C, Misztela D, Berkhout T, Broadway N, Saftig P, Reiss K . The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell-cell adhesion. Blood. 2003; 102(4):1186-95. DOI: 10.1182/blood-2002-12-3775. View

Morganti J, Nash K, Grimmig B, Ranjit S, Small B, Bickford P . The soluble isoform of CX3CL1 is necessary for neuroprotection in a mouse model of Parkinson's disease. J Neurosci. 2012; 32(42):14592-601. PMC: 3501652. DOI: 10.1523/JNEUROSCI.0539-12.2012. View

10.

Cipriani R, Villa P, Chece G, Lauro C, Paladini A, Micotti E . CX3CL1 is neuroprotective in permanent focal cerebral ischemia in rodents. J Neurosci. 2011; 31(45):16327-35. PMC: 6633249. DOI: 10.1523/JNEUROSCI.3611-11.2011. View

11.

Ma Q, Jones D, Borghesani P, Segal R, Nagasawa T, Kishimoto T . Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice. Proc Natl Acad Sci U S A. 1998; 95(16):9448-53. PMC: 21358. DOI: 10.1073/pnas.95.16.9448. View

12.

Alliot F, Godin I, Pessac B . Microglia derive from progenitors, originating from the yolk sac, and which proliferate in the brain. Brain Res Dev Brain Res. 1999; 117(2):145-52. DOI: 10.1016/s0165-3806(99)00113-3. View

13.

Parkhurst C, Yang G, Ninan I, Savas J, Yates 3rd J, Lafaille J . Microglia promote learning-dependent synapse formation through brain-derived neurotrophic factor. Cell. 2013; 155(7):1596-609. PMC: 4033691. DOI: 10.1016/j.cell.2013.11.030. View

14.

Lauro C, Di Angelantonio S, Cipriani R, Sobrero F, Antonilli L, Brusadin V . Activity of adenosine receptors type 1 Is required for CX3CL1-mediated neuroprotection and neuromodulation in hippocampal neurons. J Immunol. 2008; 180(11):7590-6. DOI: 10.4049/jimmunol.180.11.7590. View

15.

Hume D, Perry V, Gordon S . Immunohistochemical localization of a macrophage-specific antigen in developing mouse retina: phagocytosis of dying neurons and differentiation of microglial cells to form a regular array in the plexiform layers. J Cell Biol. 1983; 97(1):253-7. PMC: 2112503. DOI: 10.1083/jcb.97.1.253. View

16.

Paolicelli R, Bolasco G, Pagani F, Maggi L, Scianni M, Panzanelli P . Synaptic pruning by microglia is necessary for normal brain development. Science. 2011; 333(6048):1456-8. DOI: 10.1126/science.1202529. View

17.

Hickman S, Allison E, El Khoury J . Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci. 2008; 28(33):8354-60. PMC: 2597474. DOI: 10.1523/JNEUROSCI.0616-08.2008. View

18.

Kumar-Singh S, Pirici D, McGowan E, Serneels S, Ceuterick C, Hardy J . Dense-core plaques in Tg2576 and PSAPP mouse models of Alzheimer's disease are centered on vessel walls. Am J Pathol. 2005; 167(2):527-43. PMC: 1603563. DOI: 10.1016/S0002-9440(10)62995-1. View

19.

Boehme S, Lio F, Bacon K, Conlon P . The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol. 2000; 165(1):397-403. DOI: 10.4049/jimmunol.165.1.397. View

20.

Jonsson T, Stefansson H, Steinberg S, Jonsdottir I, Jonsson P, Snaedal J . Variant of TREM2 associated with the risk of Alzheimer's disease. N Engl J Med. 2012; 368(2):107-16. PMC: 3677583. DOI: 10.1056/NEJMoa1211103. View